ABSI
- Absci Corporation
()
Overview
Company Summary
Absci Corporation (ABSI) is a biotechnology company that specializes in drug discovery and development. The company utilizes a proprietary technology platform called SoluPro�, which enables the rapid and cost-effective creation of diverse protein-based therapeutics.
ABSI's primary focus is on the discovery and optimization of biotherapeutics, such as monoclonal antibodies, enzymes, and other protein-based drugs. These drugs can be used to target various diseases, including cancer, autoimmune disorders, and infectious diseases.
The SoluPro� platform allows Absci to overcome the challenges associated with traditional protein production methods. It enhances the efficiency of protein expression, folding, and modification, enabling large-scale production of high-quality proteins with reduced timelines and costs.
The company offers its technology as a service to pharmaceutical and biotech companies, providing them with access to a wide range of protein-based therapeutics and enabling the acceleration of their drug development efforts. Absci's technology can also be used for the discovery of new drug targets and the optimization of existing protein-based drugs.
Aside from its platform services, Absci also engages in its own internal drug discovery and development programs. By leveraging its proprietary technology, the company aims to bring novel therapies to the market more quickly and efficiently.
In summary, Absci Corporation is a biotech company that utilizes its SoluPro� platform to enable the rapid discovery, development, and production of protein-based therapeutics. Its services and internal programs aim to advance the development of new drugs and improve the treatment options for various diseases.